---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Ceribell

🌎 ceribell.com

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in acute care settings. By combining portable hardware with AI-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions, and is FDA 510(k) cleared for indicating suspected seizure activity.

---

Ceribell - Latest News and Updates

• On April 21, 2025, Ceribell received FDA clearance for its Clarity algorithm to detect pediatric seizures, expanding its EEG system's capabilities to patients aged one year and older.
• Karen B Seagraves, PhD, MPH, NEA-BC has joined Ceribell as Executive Director, Market Access and Reimbursement in the United States, previously holding a position at another company.
• On April 24, Ceribell announced new research in Neurology outlining how to implement their Clarity AI seizure detection algorithm in neurology practice.
• Dr. Rod Fontenette, an emergency physician, shared a case study on April 21 where Ceribell's EEG helped avoid unnecessary treatment and a costly transfer for a patient by quickly ruling out non-convulsive status epilepticus.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.